Abstract
Background: Urinary Tract Infections (UTIs) occur in 12% of pregnant women, which may present as asymptomatic Bacteriuria (ASB) to symptomatic bladder or kidney infections (Cystitis and Pyelonephritis, respectively). Identifying risk factors for UTI may allow for improved screening techniques and help facilitate preventative medicine in at-risk populations from dangerous UTI-related sequelae.
Methods: We used the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 which surveyed postpartum women from 2016 to 2021 to assess factors related to the occurrence of UTIs during pregnancy. PRAMS has respondents self-identifying ethnoracial groups, socioeconomic status (SES), and comorbidities, which we used to identify the associated risk of developing a UTI during pregnancy.
Results: From 2016 to 2021, we found a notable overall occurrence of UTIs—going from 12.36% to 11.32%. Results also showed significant associations between depression (OR=2.18, 95% CI), intimate partner violence (OR=1.74, 95% CI), and prescription pain relievers (OR=1.38, 95% CI) in the development of UTI during pregnancy. Maternal race affects the risk of occurrence. Compared to White women, Black (OR=1.22, 95% CI), American Indian (OR=2.24, 95% CI), and mulitracial (OR=1.17, 95% CI) women UTIs occur more frequently in pregnancy. In contrast, Asian women are less likely to experience a UTI in pregnancy (OR=0.45, 95% CI) than white women.
Conclusion: Compared to reported UTIs rates from 2000-2002 of 17%, our findings show that the occurrence of UTIs during pregnancy has decreased. Given the relevant significant findings, increased screening for depression and IPV may be warranted for those presenting with UTI. As well, increase screening for UTIs in Black, American Indian, and multiracial women to prevent development of serious sequelae.
Methods: We used the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 which surveyed postpartum women from 2016 to 2021 to assess factors related to the occurrence of UTIs during pregnancy. PRAMS has respondents self-identifying ethnoracial groups, socioeconomic status (SES), and comorbidities, which we used to identify the associated risk of developing a UTI during pregnancy.
Results: From 2016 to 2021, we found a notable overall occurrence of UTIs—going from 12.36% to 11.32%. Results also showed significant associations between depression (OR=2.18, 95% CI), intimate partner violence (OR=1.74, 95% CI), and prescription pain relievers (OR=1.38, 95% CI) in the development of UTI during pregnancy. Maternal race affects the risk of occurrence. Compared to White women, Black (OR=1.22, 95% CI), American Indian (OR=2.24, 95% CI), and mulitracial (OR=1.17, 95% CI) women UTIs occur more frequently in pregnancy. In contrast, Asian women are less likely to experience a UTI in pregnancy (OR=0.45, 95% CI) than white women.
Conclusion: Compared to reported UTIs rates from 2000-2002 of 17%, our findings show that the occurrence of UTIs during pregnancy has decreased. Given the relevant significant findings, increased screening for depression and IPV may be warranted for those presenting with UTI. As well, increase screening for UTIs in Black, American Indian, and multiracial women to prevent development of serious sequelae.
Original language | American English |
---|---|
Pages | 19 |
State | Published - 13 Sep 2024 |
Event | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health - Oklahoma State University College of Osteopathic Medicine at the Cherokee Nation, Tahlequah, United States Duration: 13 Sep 2024 → 13 Sep 2024 |
Conference
Conference | 2024 Symposium on Tribal and Rural Innovations in Disparities and Equity for Health |
---|---|
Abbreviated title | STRIDE 2024 |
Country/Territory | United States |
City | Tahlequah |
Period | 13/09/24 → 13/09/24 |